Assessing response of myeloma bone disease with diffusion-weighted MRI
- 1 December 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 85 (1020), e1198-e1203
- https://doi.org/10.1259/bjr/52759767
Abstract
Objectives: To measure apparent diffusion coefficient (ADC) values in patients with active myeloma and remission and to determine whether changes differ in those responding/progressing on treatment. The relationship between changes in marrow fat and ADC was also explored. Methods: 20 patients were recruited. T-1 weighted, T-2 weighted, short tau inversion-recovery, diffusion-weighted and two-point Dixon MRI of the lumbar spine and pelvis were performed at baseline, 4-6 weeks and 20 weeks. Results: ADC values of active disease (mean 761.2 +/- 255x10(-6) mm(2) s(-1)) were significantly higher (p=0.047) than marrow in remission (mean 601.8 +/- 459x10(-6) mm(2) s(-1)). Changes in ADC in responders showed a significant increase at 4-6 weeks (p=0.005) but no significant change between baseline and 20 weeks (p=0.733). ADCs in progressing and stable patients did not change significantly between either time point. Pearson's correlation coefficient between change in fat fraction and change in the number of pixels with an ADC of <= 655x10(-6) mm(2) s(-1) was 0.924, indicating a significant correlation (p < 0.001). Conclusion: ADC values in active myeloma are significantly higher than marrow in remission, indicating the potential for diffusion-weighted MRI to quantify the transition from active disease to remission and vice versa. This study confirms significant changes in ADC in patients responding to treatment and indirect evidence from two-point Dixon MRI suggests that these changes are influenced by changes in marrow fat. Advances in knowledge: ADC of active myeloma is significantly higher than marrow in remission; the direction of ADC changes on treatment is dependent on the timing of measurements and is influenced by changes in marrow fat.Keywords
This publication has 14 references indexed in Scilit:
- Whole-Body Diffusion-Weighted MRI With Apparent Diffusion Coefficient Mapping for Early Response Monitoring in Multiple Myeloma: Preliminary ResultsAmerican Journal of Roentgenology, 2011
- Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibilityEuropean Radiology, 2011
- Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppressionEuropean Radiology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Diffusion-weighted magnetic resonance imaging and its application to cancerCancer Imaging, 2006
- Reduction of eddy‐current‐induced distortion in diffusion MRI using a twice‐refocused spin echoMagnetic Resonance in Medicine, 2002
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.Radiology, 1988